Patents for A61P 35 - Antineoplastic agents (221,099)
05/2012
05/03/2012CA2816171A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012CA2816088A1 Metalloenzyme inhibitor compounds
05/03/2012CA2815710A1 Quinazoline derivatives
05/03/2012CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012CA2815170A1 Pyridine derivative and medicinal agent
05/03/2012CA2815119A1 Means and methods for treating dlbcl
05/03/2012CA2814907A1 Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin iii
05/03/2012CA2814436A1 Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders
05/03/2012CA2814120A1 Novel anti-cancer agents
05/03/2012CA2811805A1 Solid dispersions containing an apoptosis-inducing agent
05/02/2012EP2447370A1 MicroRNA molecules
05/02/2012EP2447283A2 Human monoclonal antibodies to activin receptor-like kinase-1 (ALK-1)
05/02/2012EP2447272A1 2'-Fluoro-2'-deoxytetrahydrouridines as cytidine deaminase inhibitors
05/02/2012EP2447268A1 Crystalline form of 13-[(N-tert-butoxycarbonyl)-2'-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III
05/02/2012EP2447258A1 Dioxanes derived from regrouping carbohydrates and c-glycosides, method for obtaining same, and uses thereof
05/02/2012EP2446899A2 Adjuvant composition comprising (poly-gamma-glutamate)-chitosan nanoparticles
05/02/2012EP2446897A1 Anti-KIR combination treatments and methods
05/02/2012EP2446893A1 Use of nontoxic cyclic peptides to block transport via OATP1B1/ OATP1B3-related proteins, for the treatment of cancer cells expressing such transporters
05/02/2012EP2446883A1 Treatment of inflammation
05/02/2012EP2445932A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012EP2445916A1 Alkoxy-thienopyrimidines as tgf-beta receptor kinase modulators
05/02/2012EP2445915A1 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
05/02/2012EP2445913A1 Tricyclic pyrimidine derivatives as wnt antagonists
05/02/2012EP2445912A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
05/02/2012EP2445910A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
05/02/2012EP2445903A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
05/02/2012EP2445885A2 Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
05/02/2012EP2445876A1 Polymorphic form d of bazedoxifene acetate and methods of preparing same
05/02/2012EP2445537A1 Conjugates of cytotoxic drugs
05/02/2012EP2445534A2 Continuous administration of cilengitide in cancer treatments
05/02/2012EP2445532A1 Compositions comprising a radiosensitizer and an anti-cancer agent and methods of uses thereof
05/02/2012EP2445529A2 Marker differentially expressed in cancer stem cells and methods of using same
05/02/2012EP2445501A2 Use of quingolide in the treatment of endometriosis, pain and cancer
05/02/2012EP2445500A1 Combination treatment op a g2 checkpoint inhibitor (sb-218078) and a chemotherapeutic agent for tumorigenic cells in solid tumors
05/02/2012EP2445497A2 Use of derivatives of indoles for the treatment of cancer
05/02/2012EP2445490A2 Methods for treating or preventing fatigue
05/02/2012EP2445345A1 Benzamide derivatives
05/02/2012EP2142518B1 3,4-dihydroquinazoline derivatives
05/02/2012EP2136803B1 Triazole derivatives which are smo antagonists
05/02/2012EP2086981B1 Compounds for inhibiting mitotic progression
05/02/2012EP1945224B1 Reduction of side effects from aromatase inhibitors used for treating breast cancer
05/02/2012EP1912932B1 Interleukin-1 and tumor necrosis factor-a modulators; syntheses of such modulators and methods of using such modulators
05/02/2012EP1861403B1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/02/2012EP1789042B1 1-alkoxy 1h-imidazo ring systems and methods
05/02/2012EP1724262B1 1-(2h)-isoquinolone derivative
05/02/2012EP1534668B1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
05/02/2012EP1517905B1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012CN1944454B Anti-cancer compound, method for extracting said compound, composition containing said compound, and its use in medicine production
05/02/2012CN1839139B Proteasome inhibitors and methods of using the same
05/02/2012CN102439453A Mitochondrial activity inhibitors of cancer-initiating cells and use thereof
05/02/2012CN102439155A Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
05/02/2012CN102439147A Vangl1 peptides and vaccines including the same
05/02/2012CN102439137A Method for preparing dendritic cells with capacity to induce cancer-specific immune response, and pharmaceutical composition and kit incorporating dendritic cells for preventing or treating cancer or inhibiting metastasis
05/02/2012CN102439134A Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
05/02/2012CN102439026A Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin
05/02/2012CN102439021A Novel galactoside inhibitors of galectins
05/02/2012CN102439012A Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
05/02/2012CN102439003A Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
05/02/2012CN102438998A Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
05/02/2012CN102438988A Resorcinol derivatives as hsp90 inhibitors
05/02/2012CN102438986A Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
05/02/2012CN102438702A Anti-mst1r antibodies and uses thereof
05/02/2012CN102438646A Treatment of metastatic tumors
05/02/2012CN102438624A Substituted fused pyrimidine compounds
05/02/2012CN102438620A Compounds, compositions and use for anticancer therapy
05/02/2012CN102438618A Compounds and methods for treating cancer and viral infections
05/02/2012CN102438616A Kinase protein binding inhibitors
05/02/2012CN102438615A Pharmaceutically active compositions comprising oxidative stress modulators (osm), new chemical entities, compositions and uses
05/02/2012CN102438612A Nitrile derivatives and their pharmaceutical use and compositions
05/02/2012CN102438609A Treatment of pancreatic cancer
05/02/2012CN102438608A Antitumor combination including ave8062 and sorafenib
05/02/2012CN102433383A Applications and correlated medicament of human STIM1 gene
05/02/2012CN102433343A Preparation method of trichina and tumor related protein gene and medical application
05/02/2012CN102433336A Micro-molecular interference ribonucleic acid (RNA) for inhibiting glioma proliferation and promoting glioma apoptosis as well as preparation method and application thereof
05/02/2012CN102432866A Preparation method of prodrug of triptolide
05/02/2012CN102432755A Multi-targeted photodynamic therapy polymer carrier and preparation method thereof
05/02/2012CN102432671A Targeting polypeptide SPSCVLP capable of inhibiting growth and transfer of liver cancer and application thereof
05/02/2012CN102432666A Novel compound separated from Actinostemma tenerum as well as preparation method and application thereof
05/02/2012CN102432663A Celastrol derivative and preparation method thereof and application of celastrol derivative to preparation of antitumor medicine
05/02/2012CN102432658A Method for synthesizing androstane-17(20)-alkenyl-21-ketone
05/02/2012CN102432654A Gemcitabine amide derivates, and preparation method and application thereof
05/02/2012CN102432639A 1-(2-hydroxy-3-(phenylamino)propyl)-3-ferrocenyl-1H-pyrazole-5-ethyl formate compound and medicinal use thereof
05/02/2012CN102432624A Preparation technology for crystal of dithiole pyrrolones compound
05/02/2012CN102432622A 4-amino oxadiazole epipodophyllotoxin derivative and preparation method and application thereof
05/02/2012CN102432612A 4,7-dihydrotetrazole[1,5-a]pyrimidine derivative and application thereof to preparation of antitumor medicine
05/02/2012CN102432605A Kinase inhibitor containing methyl-D3
05/02/2012CN102432595A N-indole-1-amides compounds and application of N-indole-1-amides compounds as anti-cancer drugs
05/02/2012CN102432592A Aryl urea derivate having anti-tumor function and preparation method of aryl urea derivate
05/02/2012CN102432544A 5-substituted benzyl methylene imidazole alkyl-2,4-diketone derivative and application thereof
05/02/2012CN102432485A Alpha,beta-diamino acid derivative and synthetic method and application thereof
05/02/2012CN102432447A Cyclopentanone-containing curcumin monocarbonyl structural analogues and application thereof
05/02/2012CN102430118A Application of H22 liver cancer cell autophagosome to preparation of liver cancer therapeutic vaccine
05/02/2012CN102430095A Medicine for treating lung cancer
05/02/2012CN102430088A Formula and preparation process of multifunctional Chinese herbal medicine bag
05/02/2012CN102430055A Combined medicine for treating digestive tract cancer and preparation method thereof
05/02/2012CN102430054A Traditional Chinese medicinal compound preparation for removing toxicity, resisting cancer, activating blood and dissipating mass as well as applications thereof
05/02/2012CN102430041A Method for extracting total saponins of cochinchinese asparagus root by using ultrasonic waves
05/02/2012CN102430029A Nano microcapsule for six ingredients with rehmannia and preparation process thereof